These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Anti-IL-16 therapy reduces CD4+ T-cell infiltration and improves paralysis and histopathology of relapsing EAE. Skundric DS; Dai R; Zakarian VL; Bessert D; Skoff RP; Cruikshank WW; Kurjakovic Z J Neurosci Res; 2005 Mar; 79(5):680-93. PubMed ID: 15682385 [TBL] [Abstract][Full Text] [Related]
8. Differential cytokine and chemokine production characterizes experimental autoimmune meningitis and experimental autoimmune encephalomyelitis. Perrin PJ; Rumbley CA; Beswick RL; Lavi E; Phillips SM Clin Immunol; 2000 Feb; 94(2):114-24. PubMed ID: 10637096 [TBL] [Abstract][Full Text] [Related]
9. Essential role of TGF-beta in the natural resistance to experimental allergic encephalomyelitis in rats. Cautain B; Damoiseaux J; Bernard I; van Straaten H; van Breda Vriesman P; Boneu B; Druet P; Saoudi A Eur J Immunol; 2001 Apr; 31(4):1132-40. PubMed ID: 11298338 [TBL] [Abstract][Full Text] [Related]
10. Induction of resistance to active experimental allergic encephalomyelitis by myelin basic protein-specific Th2 cell lines generated in the presence of glucocorticoids and IL-4. Ramírez F; Mason D Eur J Immunol; 2000 Mar; 30(3):747-58. PubMed ID: 10741389 [TBL] [Abstract][Full Text] [Related]
11. Late B cell depletion with a human anti-human CD20 IgG1κ monoclonal antibody halts the development of experimental autoimmune encephalomyelitis in marmosets. Kap YS; van Driel N; Blezer E; Parren PW; Bleeker WK; Laman JD; Craigen JL; 't Hart BA J Immunol; 2010 Oct; 185(7):3990-4003. PubMed ID: 20739677 [TBL] [Abstract][Full Text] [Related]
12. Combined treatment of acute EAE in Lewis rats with TNF-binding protein and interleukin-1 receptor antagonist. Wiemann B; Van GY; Danilenko DM; Yan Q; Matheson C; Munyakazi L; Ogenstad S; Starnes CO Exp Neurol; 1998 Feb; 149(2):455-63. PubMed ID: 9500957 [TBL] [Abstract][Full Text] [Related]
13. Combined nasal administration of encephalitogenic myelin basic protein peptide 68-86 and IL-10 suppressed incipient experimental allergic encephalomyelitis in Lewis rats. Xu LY; Yang JS; Huang YM; Levi M; Link H; Xiao BG Clin Immunol; 2000 Sep; 96(3):205-11. PubMed ID: 10964538 [TBL] [Abstract][Full Text] [Related]
14. A new role for interleukin-7 in the induction of LFA-1 and VLA-4 adhesion molecules in Phorbol 12myristate 13acetate activated CD4+ CD23+ T-cell subset. Fratazzi C; Carini C Clin Exp Allergy; 1997 Nov; 27(11):1335-43. PubMed ID: 9420139 [TBL] [Abstract][Full Text] [Related]
15. Evidence that Fas and FasL contribute to the pathogenesis of experimental autoimmune encephalomyelitis. Dittel BN Arch Immunol Ther Exp (Warsz); 2000; 48(5):381-8. PubMed ID: 11140465 [TBL] [Abstract][Full Text] [Related]
16. Suppression of experimental autoimmune encephalomyelitis with a TNF binding protein (TNFbp) correlates with down-regulation of VCAM-1/VLA-4. Selmaj K; Walczak A; Mycko M; Berkowicz T; Kohno T; Raine CS Eur J Immunol; 1998 Jun; 28(6):2035-44. PubMed ID: 9645385 [TBL] [Abstract][Full Text] [Related]
17. Experimental autoimmune encephalomyelitis in NF-kappa B-deficient mice:roles of NF-kappa B in the activation and differentiation of autoreactive T cells. Hilliard B; Samoilova EB; Liu TS; Rostami A; Chen Y J Immunol; 1999 Sep; 163(5):2937-43. PubMed ID: 10453042 [TBL] [Abstract][Full Text] [Related]
18. Discordant effects of anti-VLA-4 treatment before and after onset of relapsing experimental autoimmune encephalomyelitis. Theien BE; Vanderlugt CL; Eagar TN; Nickerson-Nutter C; Nazareno R; Kuchroo VK; Miller SD J Clin Invest; 2001 Apr; 107(8):995-1006. PubMed ID: 11306603 [TBL] [Abstract][Full Text] [Related]
19. A natural anti-T-cell receptor monoclonal antibody protects against experimental autoimmune encephalomyelitis. Fernández-Malavé E; Stark-Aroeira L J Neuroimmunol; 2011 May; 234(1-2):63-70. PubMed ID: 21396721 [TBL] [Abstract][Full Text] [Related]
20. NOS2 regulates cytokine production and VLA-4 expression in experimental autoimmune encephalomyelitis. Cross AH; Ramsbottom MJ; Lyons JA J Neuroimmunol; 2006 Apr; 173(1-2):79-86. PubMed ID: 16448705 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]